Insights Into the Emerging Entity of HER2‐Low Breast Cancer
Insights Into the Emerging Entity of HER2‐Low Breast Cancer
About this item
Full title
Author / Creator
Publisher
Egypt: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Egypt: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Human epidermal growth factor receptor 2 (HER2)‐low breast cancer (BC) is a subtype of BC that has been recently recognized as a separate clinical entity with distinct clinical and molecular characteristics. It is defined by a low level of HER2 protein expression, which distinguishes it from other more aggressive BC subtypes. Early studies suggest...
Alternative Titles
Full title
Insights Into the Emerging Entity of HER2‐Low Breast Cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_32af246aacb24938b1ab5dad5d5d68ae
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_32af246aacb24938b1ab5dad5d5d68ae
Other Identifiers
ISSN
2090-3170,2090-3189
E-ISSN
2090-3189
DOI
10.1155/2024/2853007
